Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
K Seppi, K Ray Chaudhuri, M Coelho… - Movement …, 2019 - Wiley Online Library
Objective To update evidence‐based medicine recommendations for treating nonmotor
symptoms in Parkinson's disease (PD). Background The International Parkinson and …
symptoms in Parkinson's disease (PD). Background The International Parkinson and …
REM sleep behaviour disorder
Y Dauvilliers, CH Schenck, RB Postuma… - Nature reviews Disease …, 2018 - nature.com
Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia that is
characterized by loss of muscle atonia during REM sleep (known as REM sleep without …
characterized by loss of muscle atonia during REM sleep (known as REM sleep without …
Pharmacological treatment of Parkinson disease: a review
BS Connolly, AE Lang - Jama, 2014 - jamanetwork.com
Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …
worldwide. Although no available therapies alter the underlying neurodegenerative process …
Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
M Howell, AY Avidan, N Foldvary-Schaefer… - Journal of Clinical …, 2023 - jcsm.aasm.org
This systematic review provides supporting evidence for a clinical practice guideline for the
management of rapid eye movement (REM) sleep behavior disorder in adults and children …
management of rapid eye movement (REM) sleep behavior disorder in adults and children …
Rapid eye movement sleep behavior disorder and neurodegenerative disease
MJ Howell, CH Schenck - JAMA neurology, 2015 - jamanetwork.com
Importance The dream enactment of rapid eye movement sleep behavior disorder (RBD) is
often the first indication of an impending α-synuclein disorder, such as Parkinson disease …
often the first indication of an impending α-synuclein disorder, such as Parkinson disease …
The cholinergic brain in Parkinson's disease
The central cholinergic system includes the basal forebrain nuclei, mainly projecting to the
cortex, the mesopontine tegmental nuclei, mainly projecting to the thalamus and subcortical …
cortex, the mesopontine tegmental nuclei, mainly projecting to the thalamus and subcortical …
The treatment of sleep disorders in Parkinson's disease: from research to clinical practice
G Loddo, G Calandra-Buonaura, L Sambati… - Frontiers in …, 2017 - frontiersin.org
Sleep disorders (SDs) are one of the most frequent non-motor symptoms of Parkinson's
disease (PD), usually increasing in frequency over the course of the disease and disability …
disease (PD), usually increasing in frequency over the course of the disease and disability …
[HTML][HTML] Sleep issues in Parkinson's disease and their management
JRP Zuzuárregui, EH During - Neurotherapeutics, 2020 - Elsevier
Parkinson's disease (PD) is an alpha-synucleinopathy that leads to prominent motor
symptoms including tremor, bradykinesia, and postural instability. Nonmotor symptoms …
symptoms including tremor, bradykinesia, and postural instability. Nonmotor symptoms …
Neuroprotective effect of melatonin on Sleep disorders Associated with Parkinson's Disease
X Hu, J Li, X Wang, H Liu, T Wang, Z Lin, N Xiong - Antioxidants, 2023 - mdpi.com
Parkinson's disease (PD) is a complex, multisystem disorder with both neurologic and
systemic manifestations, which is usually associated with non-motor symptoms, including …
systemic manifestations, which is usually associated with non-motor symptoms, including …